Vertex Pharmaceuticals

YTD

ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.

CEO

Reshma Kewalramani

CEOReshma Kewalramani

Employees

6,100

Employees6,100

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1989

Founded1989

Employees

6,100

Employees6,100

VRTX Key Statistics

Market cap

101.33B

Market cap101.33B

Price-Earnings ratio

28.41

Price-Earnings ratio28.41

Dividend yield

—

Dividend yield—

Average volume

1.79M

Average volume1.79M

High today

$403.58

High today$403.58

Low today

$394.32

Low today$394.32

Open price

$400.00

Open price$400.00

Volume

1.40M

Volume1.40M

52 Week high

$519.88

52 Week high$519.88

52 Week low

$362.50

52 Week low$362.50

VRTX News

Simply Wall St 14h

Can Vertex Stock Bounce Back After 17% Drop and Promising Gene Therapy Results?

Advertisement Thinking About Vertex Pharmaceuticals Stock? Here’s What You Need to Know If you’ve been watching Vertex Pharmaceuticals lately, you’re definite...

TipRanks 6d

Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline

Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals, retaining the price target of $530.00. Elevate Your Investing Strategy:...

Analyst ratings

59%

of 34 ratings

Buy

58.8%

Hold

38.2%

Sell

2.9%

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.